{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:56:39Z","timestamp":1782226599382,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["GS00F173CA"],"award-info":[{"award-number":["GS00F173CA"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10620-022-07707-1","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T06:06:01Z","timestamp":1664431561000},"page":"1237-1252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States"],"prefix":"10.1007","volume":"68","author":[{"given":"Aynur","family":"Unalp-Arida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-9859","authenticated-orcid":false,"given":"Constance E.","family":"Ruhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"7707_CR1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1053\/j.gastro.2021.10.017","volume":"162","author":"AF Peery","year":"2022","unstructured":"Peery AF, Crockett SD, Murphy CC et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2021. Gastroenterology. 2022;162:621\u2013644.","journal-title":"Gastroenterology."},{"key":"7707_CR2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:106058","volume-title":"Deaths: Final data for 2019. National Vital Statistics Reports; vol 70 no 08","author":"JQ Xu","year":"2021","unstructured":"Xu JQ, Murphy SL, Kochanek KD, Arias E. Deaths: Final data for 2019. National Vital Statistics Reports; vol 70 no 08. Hyattsville, MD: National Center for Health Statistics; 2021."},{"key":"7707_CR3","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/hep.28390","volume":"63","author":"A Unalp-Arida","year":"2016","unstructured":"Unalp-Arida A, Ruhl CE. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population. Hepatology. 2016;63:1170\u20131183.","journal-title":"Hepatology."},{"key":"7707_CR4","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J et al. NASH clinical research network (CRN). Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021;385:1559\u20131569.","journal-title":"N Engl J Med."},{"key":"7707_CR5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2021.04.074","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal F, Shubrook JH, Younossi Z et al. Preparing for the NASH epidemic: A call to action. Gastroenterology. 2021;161:1030\u20131042.","journal-title":"Gastroenterology."},{"key":"7707_CR6","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal F, Shubrook JH, Adams LA et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology. 2021;161:1657\u20131669.","journal-title":"Gastroenterology."},{"key":"7707_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73:202\u2013209.","journal-title":"J Hepatol."},{"key":"7707_CR8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/liv.14828","volume":"41","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Perseghin G. Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver Int. 2021;41:1290\u20131293.","journal-title":"Liver Int."},{"key":"7707_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/hep.32131","volume":"75","author":"LA van Kleef","year":"2022","unstructured":"van Kleef LA, Ayada I, Alferink LJM, Pan Q, de Knegt RJ. Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study. Hepatology. 2022;75:419\u2013429.","journal-title":"Hepatology."},{"key":"7707_CR10","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.cgh.2020.10.046","volume":"19","author":"VW Wong","year":"2021","unstructured":"Wong VW, Wong GL, Woo J et al. Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease. Clin Gastroenterol Hepatol. 2021;19:2161\u20132171.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7707_CR11","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","volume":"160","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Corey KE, Lim JK. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: Expert review. Gastroenterology. 2021;160:912\u2013918.","journal-title":"Gastroenterology."},{"key":"7707_CR12","doi-asserted-by":"publisher","first-page":"e1438","DOI":"10.1016\/j.cgh.2021.06.029","volume":"20","author":"D Kim","year":"2022","unstructured":"Kim D, Konyn P, Cholankeril G, Ahmed A. Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by fibroscan. Clin Gastroenterol Hepatol. 2022;20:e1438\u2013e1455.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7707_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32207","author":"E Vilar-Gomez","year":"2021","unstructured":"Vilar-Gomez E, Nephew LD, Vuppalanchi R et al. High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population. Hepatology. 2021. https:\/\/doi.org\/10.1002\/hep.32207.","journal-title":"Hepatology."},{"key":"7707_CR14","doi-asserted-by":"publisher","first-page":"106903","DOI":"10.1016\/j.ypmed.2021.106903","volume":"154","author":"NI Heredia","year":"2022","unstructured":"Heredia NI, Zhang X, Balakrishnan M et al. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of US adults using NHANES 2017\u20132018. Prev Med. 2022;154:106903.","journal-title":"Prev Med."},{"key":"7707_CR15","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. NIDDK Strategic Plan for Research. Dec. 2021. Available at: https:\/\/www.niddk.nih.gov\/about-niddk\/strategic-plans-reports\/niddk-strategic-plan-for-research. Accessed April 5, 2022."},{"key":"7707_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clinre.2011.08.001","volume":"36","author":"M Sasso","year":"2012","unstructured":"Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan\u00ae. Clin Res Hepatol Gastroenterol. 2012;36:13\u201320.","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"7707_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200656","volume":"13","author":"N Fabrellas","year":"2018","unstructured":"Fabrellas N, Hernandez R, Graupera I et al. Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study. PLoS ONE. 2018;13:e0200656.","journal-title":"PLoS ONE."},{"key":"7707_CR18","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.cgh.2020.08.017","volume":"19","author":"D Kim","year":"2021","unstructured":"Kim D, Cholankeril G, Loomba R, Ahmed A. Prevalence of fatty liver disease and fibrosis detected by transient elastography in adults in the United States, 2017\u20132018. Clin Gastroenterol Hepatol. 2021;19:1499\u20131501.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"6","key":"7707_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252164","volume":"16","author":"X Zhang","year":"2021","unstructured":"Zhang X, Heredia NI, Balakrishnan M, Thrift AP. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017\u20132018. PLoS ONE. 2021;16:e0252164.","journal-title":"PLoS ONE."},{"issue":"9","key":"7707_CR20","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/hep4.1981","volume":"6","author":"E Truong","year":"2022","unstructured":"Truong E, Yeo YH, Cook-Wiens G, et al. Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017\u20132018. Hepatol Commun. 2022;6:2253\u20132261.","journal-title":"Hepatol Commun."},{"key":"7707_CR21","unstructured":"National Center for Health Statistics. National Health and Nutrition Examination Survey 2017-2018 Liver Ultrasound Transient Elastography Procedures Manual. Available at: https:\/\/wwwn.cdc.gov\/nchs\/data\/nhanes\/2017-2018\/manuals\/2018_Liver_Ultrasound_Elastography_Procedures_Manual.pdf. Accessed April 5, 2022."},{"key":"7707_CR22","doi-asserted-by":"publisher","first-page":"e808","DOI":"10.1016\/j.cgh.2021.02.009","volume":"20","author":"A Unalp-Arida","year":"2022","unstructured":"Unalp-Arida A, Ruhl CE. Transient elastography-assessed hepatic steatosis and fibrosis are associated with body composition in the United States. Clin Gastroenterol Hepatol. 2022;20:e808\u2013e830.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7707_CR23","unstructured":"National Center for Health Statistics. National Health and Nutrition Examination Survey. Available at: https:\/\/www.cdc.gov\/nchs\/nhanes\/index.htm. Accessed April 5, 2022."},{"key":"7707_CR24","unstructured":"World Health Organization. Global Physical Activity Questionnaire (GPAQ) Analysis Guide. Available at: https:\/\/cdn.who.int\/media\/docs\/default-source\/ncds\/ncd-surveillance\/gpaq-analysis-guide.pdf?sfvrsn=1e83d571_2. Accessed April 5, 2022."},{"key":"7707_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/hep.29489","volume":"67","author":"R Vuppalanchi","year":"2018","unstructured":"Vuppalanchi R, Siddiqui MS, Van Natta ML et al. NASH clinical research network. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018;67:134\u2013144.","journal-title":"Hepatology."},{"key":"7707_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Vuppalanchi R, Van Natta ML et al. NASH clinical research network. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17:156\u2013163.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7707_CR27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1717\u20131730.","journal-title":"Gastroenterology."},{"key":"7707_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u2013357.","journal-title":"Hepatology."},{"key":"7707_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/9781118548387.ch4","volume-title":"Applied Logistic Regression","author":"DW Hosmer","year":"2013","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression, 3rd edn. Hoboken, NJ: Wiley; 2013; 89\u2013149.","edition":"3"},{"key":"7707_CR30","first-page":"48","volume-title":"Statistical Methods in Cancer Research: the Design and Analysis of Cohort Studies","author":"NE Breslow","year":"1987","unstructured":"Breslow NE, Day NE. Statistical Methods in Cancer Research: the Design and Analysis of Cohort Studies, Lyon: International Agency for Research on Cancer; 1987; 48\u201379."},{"key":"7707_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2337\/dc20-1778","volume":"44","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Monti T, Perseghin G. High prevalence of advanced liver fibrosis assessed by transient elastography among U.S. adults with type 2 diabetes. Diabetes Care. 2021;44:519\u2013525.","journal-title":"Diabetes Care."},{"key":"7707_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.32163","volume":"75","author":"P Gin\u00e8s","year":"2022","unstructured":"Gin\u00e8s P, Castera L, Lammert F et al. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2022;75:219\u2013228.","journal-title":"Hepatology."},{"key":"7707_CR33","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1136\/gut.2010.221382","volume":"60","author":"D Roulot","year":"2011","unstructured":"Roulot D, Costes JL, Buyck JF et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut. 2011;60:977\u2013984.","journal-title":"Gut."},{"key":"7707_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/hep.27981","volume":"63","author":"EM Koehler","year":"2016","unstructured":"Koehler EM, Plompen EP, Schouten JN et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study. Hepatology. 2016;63:138\u2013147.","journal-title":"Hepatology."},{"key":"7707_CR35","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.cgh.2017.12.048","volume":"16","author":"L Caballer\u00eda","year":"2018","unstructured":"Caballer\u00eda L, Pera G, Arteaga I et al. High prevalence of liver fibrosis among European adults with unknown liver disease: A population-based study. Clin Gastroenterol Hepatol. 2018;16:1138\u20131145.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7707_CR36","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1111\/liv.13743","volume":"38","author":"S Petta","year":"2018","unstructured":"Petta S, Di Marco V, Pipitone RM et al. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population. Liver Int. 2018;38:2060\u20132068.","journal-title":"Liver Int."},{"key":"7707_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2468-1253(19)30419-4","volume":"5","author":"KWM Abeysekera","year":"2020","unstructured":"Abeysekera KWM, Fernandes GS, Hammerton G et al. Prevalence of steatosis and fibrosis in young adults in the UK: A population-based study. Lancet Gastroenterol Hepatol. 2020;5:295\u2013305.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"7707_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","volume":"61","author":"VW Wong","year":"2012","unstructured":"Wong VW, Chu WC, Wong GL et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: A population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012;61:409\u2013415.","journal-title":"Gut."},{"issue":"11","key":"7707_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-230X-11-70","volume":"13","author":"M Baba","year":"2011","unstructured":"Baba M, Furuya K, Bandou H, Kasai K, Sadaoka K. Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: A cross section study. BMC Gastroenterol. 2011;13:70.","journal-title":"BMC Gastroenterol."},{"key":"7707_CR40","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3748\/wjg.v21.i4.1158","volume":"21","author":"SC You","year":"2015","unstructured":"You SC, Kim KJ, Kim SU et al. Factors associated with significant liver fibrosis assessed using transient elastography in general population. World J Gastroenterol. 2015;21:1158\u20131166.","journal-title":"World J Gastroenterol."},{"key":"7707_CR41","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","volume":"75","author":"D Kim","year":"2021","unstructured":"Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol. 2021;75:1284\u20131291.","journal-title":"J Hepatol."},{"key":"7707_CR42","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/hep4.1765","volume":"5","author":"SA Alqahtani","year":"2021","unstructured":"Alqahtani SA, Paik JM, Biswas R, Arshad T, Henry L, Younossi ZM. Poor awareness of liver disease among adults with NAFLD in the United States. Hepatol Commun. 2021;5:1833\u20131847.","journal-title":"Hepatol Commun."},{"key":"7707_CR43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D et al. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022;28:528\u2013562.","journal-title":"Endocr Pract."},{"key":"7707_CR44","doi-asserted-by":"publisher","first-page":"e1456","DOI":"10.1016\/j.cgh.2021.06.048","volume":"20","author":"ZM Younossi","year":"2022","unstructured":"Younossi ZM, Ong JP, Takahashi H et al. A global survey of physicians knowledge about nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2022;20:e1456\u2013e1468.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7707_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/hep.29113","volume":"66","author":"A Unalp-Arida","year":"2017","unstructured":"Unalp-Arida A, Ruhl CE. Liver fibrosis scores predict liver disease mortality in the United States population. Hepatology. 2017;66:84\u201395.","journal-title":"Hepatology."},{"key":"7707_CR46","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.metabol.2009.11.020","volume":"59","author":"ES Ford","year":"2010","unstructured":"Ford ES, Li C, Zhao G, Pearson WS, Tsai J, Churilla JR. Sedentary behavior, physical activity, and concentrations of insulin among US adults. Metabolism. 2010;59:1268\u20131275.","journal-title":"Metabolism."},{"issue":"1","key":"7707_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2020-000960","volume":"7","author":"S Stockwell","year":"2021","unstructured":"Stockwell S, Trott M, Tully M et al. Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: A systematic review. BMJ Open Sport Exerc Med. 2021;7:e000960.","journal-title":"BMJ Open Sport Exerc Med."},{"key":"7707_CR48","unstructured":"Office of the Assistant Secretary for Planning and Evaluation. 2020 Poverty Guidelines. Available at: https:\/\/aspe.hhs.gov\/topics\/poverty-economic-mobility\/poverty-guidelines\/prior-hhs-poverty-guidelines-federal-register-references\/2020-poverty-guidelines. Accessed April 5, 2022."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07707-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07707-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07707-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T04:23:19Z","timestamp":1681359799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07707-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["7707"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07707-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.05.22273458","asserted-by":"object"}]},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Unalp-Arida: The National Institute of Diabetes and Digestive and Kidney Diseases is a funding collaborator with the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS) through the United States Government Interagency Agreement (IAA) Number ADK15006 (also known as IAA# 164 at NCHS). Dr. Ruhl: No conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}